Protagenic Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-2.6M | $-2.3M | $-2.3M | $-1.0M | $-1.1M |
| Depreciation & Amortization | — | — | — | — | — |
| Depreciation | $347 | $148 | $534 | $143 | $0 |
| Amortization | — | — | — | — | — |
| Stock-Based Compensation | $1.1M | $888.3K | $546.1K | $478.6K | $275.0K |
| Net Cash from Operating Activities | $-1.1M | $-1.4M | $-1.1M | $-381.3K | $-790.0K |
| Investing Activities | |||||
| Capital Expenditures | — | — | — | $1.8K | $1.0K |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | $1.0M | $-1.3M | — | — | — |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $4.3M | — | — |
| Net Change in Cash | $-37.2K | $-2.7M | $3.1M | $-19.4K | $-616.0K |
| Free Cash Flow | — | — | — | $-383.1K | $-791.0K |